Omalizumab in the management of oral corticosteroid-dependent IGE-mediated asthma patients. [electronic resource]
Producer: 20110401Description: 45-53 p. digitalISSN:- 1473-4877
- Administration, Oral
- Adrenal Cortex Hormones -- administration & dosage
- Adult
- Aged
- Anti-Asthmatic Agents -- administration & dosage
- Antibodies, Anti-Idiotypic
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Humanized
- Asthma -- drug therapy
- Dose-Response Relationship, Drug
- Drug Therapy, Combination
- Female
- Follow-Up Studies
- Humans
- Immunoglobulin E -- adverse effects
- Male
- Middle Aged
- Omalizumab
- Time Factors
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.